PROGRESSIVE MUSCULAR ATROPHY
|
ALTERNATE NAMES
|
Duchenne–Aran Muscular Atrophy; PMA
|
DESCRIPTION
|
Progressive Muscular Atrophy (PMA) is a rare, sporadic, adult-onset motor neuron disease. PMA is a clinical disorder
characterized by degeneration of lower motor neurons. These types of motor neurons
directly innervate skeletal muscles and control voluntary movements.
Motor neuron diseases are a group of disorders characterized by progressive damage
to an individual’s motor neurons, the cells in the nervous system that allow an individual
to perform functions such as speech, breathing, and movement.
|
DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND ICD-9-CM/ICD-10-CM CODING
|
Diagnostic testing: Diagnostic testing for PMA may include:
-
•
Medical and family history;
-
•
Cerebrospinal fluid analysis;
-
•
Computed tomography (CT) scans;
-
•
Magnetic resonance imaging (MRI) scans;
-
•
Muscle and nerve biopsies;
-
•
Nerve conduction velocity (NCV) test; and
Physical findings: Signs and symptoms of PMA include:
-
•
Difficulty with motor function leading to clumsiness;
-
•
Inability to use the arms (flail arm syndrome);
-
•
Unexplained weight loss; and
-
•
Weakness in hands, arms, core, or legs.
ICD-9: 335.29
ICD-10: G11.4; G12.1; G12.25
|
PROGRESSION
|
PMA is progressive, which means it will worsen over time. It often progresses very
gradually and may affect only one part of the body for several years. PMA is fatal.
However, the length of time an individual will live with the disease fluctuates. The
life expectancy averages 5 to 10 years.
Individuals with PMA eventually develop upper motor neuron damage, which more resembles
an amyotrophic lateral sclerosis (ALS) diagnosis.
|
TREATMENT
|
There is no cure for PMA. Treatment is designed to slow down the damage to maintain
a good quality of life for as long as possible.
Although there is no standard treatment for PMA, doctors work with patients to develop
a treatment plan to help manage symptoms. Treatments may include medication, nutritional
counseling, physical therapy, and occupational therapy.
Doctors may prescribe Riluzole, a medication typically used for ALS, to slow down
damage to motor neurons. Other medications are used to treat pain, muscle cramping,
and twitching.
|
SUGGESTED PROGRAMMATIC ASSESSMENT*
|
Suggested MER for Evaluation:
-
•
Clinical history and examination that describes the diagnostic features of the impairment;
-
•
Results of imaging (CT scan and MRI);
-
•
Results of EMG and NCV testing; and
-
•
Results of lumbar puncture and muscle and nerve biopsy.
|
Suggested Listings for Evaluation:
|
DETERMINATION
|
LISTING
|
REMARKS
|
Meets
|
11.22
|
|
Equals
|
|
|
* Adjudicators may, at their discretion, use the Medical Evidence of Record or the
listings suggested to evaluate the claim. However, the decision to allow or deny the
claim rests with the adjudicator.
|